Product code KXT— Clinical Toxicology

CEDIA DIGOXIN PLUS ASSAY

Classification name
Enzyme Immunoassay, Digoxin
Device class
Class 2
Regulation
21 CFR 862.3320
Advisory panel
Clinical Toxicology
Total cleared
85
First cleared
Most recent

Market context for product code KXT

FDA has cleared 85 devices under product code KXT between 1979 and 2021, filed by 46 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

last 15 years

Top applicants under product code KXT

Recent clearances under product code KXT

Data sourced from openFDA. This site is unofficial and independent of the FDA.